Qube Research & Technologies Ltd - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 263 filers reported holding CYTOKINETICS INC in Q1 2023. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$285,998
-90.8%
9,708
-89.8%
0.00%
-90.9%
Q2 2023$3,117,037
-13.6%
95,556
-6.8%
0.01%
-31.2%
Q1 2023$3,606,905
+716.0%
102,498
+728.3%
0.02%
+166.7%
Q3 2021$442,000
+48.3%
12,374
-10.0%
0.01%
+50.0%
Q3 2020$298,000
-47.0%
13,748
-42.3%
0.00%
-50.0%
Q2 2020$562,00023,8390.01%
Other shareholders
CYTOKINETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,723,170$13,940,0005.01%
RP Management, LLC 875,656$7,084,0003.54%
BVF INC/IL 3,801,817$30,757,0003.44%
DAFNA Capital Management LLC 400,294$3,238,0001.40%
Virtus ETF Advisers LLC 33,758$273,0000.58%
IRONWOOD INVESTMENT MANAGEMENT LLC 67,352$545,0000.44%
WASATCH ADVISORS LP 3,188,487$25,795,0000.28%
LANSDOWNE PARTNERS (UK) LLP 1,459,706$11,809,0000.26%
Campbell & CO Investment Adviser LLC 43,844$355,0000.18%
Fosun International Ltd 239,792$1,981,0000.13%
View complete list of CYTOKINETICS INC shareholders